BlackBarn Capital Partners LP Has $16.84 Million Stake in Privia Health Group, Inc. $PRVA

Key Points

• BlackBarn Capital Partners LP increased its stake in Privia Health Group, Inc. by 13.1% during the first quarter, owning 750,000 shares and ranking it as their 6th largest holding.
• Institutional ownership is significant, with approximately 94.48% of Privia Health Group’s stock held by hedge funds and other institutional investors.
• Equity analysts have mixed ratings on Privia Health, with the consensus rating being a "Moderate Buy" and an average target price of $28.00.

BlackBarn Capital Partners LP lifted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 13.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 750,000 shares of the company's stock after buying an additional 86,603 shares during the quarter. Privia Health Group comprises 1.1% of BlackBarn Capital Partners LP's portfolio, making the stock its 6th biggest holding. BlackBarn Capital Partners LP owned about 0.62% of Privia Health Group worth $16,838,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. US Bancorp DE lifted its holdings in Privia Health Group by 2.4% during the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock worth $415,000 after buying an additional 429 shares in the last quarter. Park Avenue Securities LLC lifted its stake in shares of Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock valued at $342,000 after acquiring an additional 532 shares during the period. CWM LLC boosted its holdings in Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after acquiring an additional 604 shares during the last quarter. Financial Management Professionals Inc. increased its position in Privia Health Group by 28.7% in the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock worth $76,000 after purchasing an additional 754 shares during the period. Finally, GAMMA Investing LLC raised its holdings in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after purchasing an additional 1,521 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Price Performance

NASDAQ:PRVA traded up $0.36 during trading hours on Wednesday, reaching $21.75. 514,199 shares of the stock were exchanged, compared to its average volume of 837,944. The stock has a market cap of $2.67 billion, a PE ratio of 197.75, a PEG ratio of 3.10 and a beta of 0.80. Privia Health Group, Inc. has a twelve month low of $16.47 and a twelve month high of $26.09. The firm has a 50 day moving average of $20.89 and a 200 day moving average of $22.68.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same period last year, the business posted $0.19 EPS. The firm's revenue for the quarter was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PRVA has been the subject of several analyst reports. JPMorgan Chase & Co. lifted their price target on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 28th. Piper Sandler lowered their target price on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a report on Monday, August 11th. Barclays upped their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 27th. Zacks Research upgraded Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. Finally, Evercore ISI reduced their target price on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $28.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.